Patent Trial and Appeal Board to challenge Eli Lilly patent claims on tirzepatide
After the shortage ended, 503B bulk compounding of tirzepatide is effectively blocked, and the FDA proposed in April 2026 to keep it off the 503B bulks list
Similarly, if youre seeing excellent results at your current dose, theres no rush to increase
If you experience the side effect of GERD (gastroesophageal reflux disease) , however, it may take a little more than patience to ameliorate your symptoms
In June, a paper in JAMA Ophthalmology looked at age-related macular degeneration in people with Type 2 diabetes who were taking GLP-1 drugs
While no previous studies have examined the combined effects of ALA and L-carnitine in migraine, some have investigated the separate effects of animal-based omega-3s and L-carnitine, yielding conflicting results